Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 7
Submit an article Journal homepage
393
Views
3
CrossRef citations to date
0
Altmetric
Articles

COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study

Оlga L. Kochnevaa City Clinical Hospital No. 52, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-1338-8203
ORCID Icon,
Maria Kislovab Botkin Hospital, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-8794-0120
ORCID Icon,
Evgenya I. Zhelnovaa City Clinical Hospital No. 52, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-0343-9348
ORCID Icon,
Andrei A. Petrenkoc Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian Federation;d Department of Radio Engineering and Cybernetics, Moscow Institute of Physics and Technology, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0001-8461-5421
ORCID Icon,
Elena A. Baryakha City Clinical Hospital No. 52, Moscow, Russia;c Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian FederationORCID Iconhttps://orcid.org/0000-0001-6880-9269
ORCID Icon,
Konstantin V. Yatskova City Clinical Hospital No. 52, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-0125-9068
ORCID Icon,
Elena A. Dmitrievab Botkin Hospital, Moscow, Russia;c Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian FederationORCID Iconhttps://orcid.org/0000-0002-3866-4510
ORCID Icon,
Elena N. Misurinaa City Clinical Hospital No. 52, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-2419-4850
ORCID Icon,
Konstantin E. Nikitind Department of Radio Engineering and Cybernetics, Moscow Institute of Physics and Technology, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0001-8165-7255
ORCID Icon,
Elena J. Vasilievae Davidovsky City Clinical Hospital, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0003-4111-0874
ORCID Icon,
Inna V. Samsonovaa City Clinical Hospital No. 52, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-1228-1765
ORCID Icon,
Vadim V. Ptushkinb Botkin Hospital, Moscow, Russia;c Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian FederationORCID Iconhttps://orcid.org/0000-0002-9368-6050
ORCID Icon,
Ancha Baranovaf School of Systems Biology, George Mason University, Fairfax, VA, USA;g Research Center for Medical Genetics, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0001-6810-5982
ORCID Icon &
Eugene A. Nikitinb Botkin Hospital, Moscow, Russia;c Federal State Budgetary Educational Institution of Further Professional Education “Russian Medical Academy of Continuous Professional Education” of the Ministry of Healthcare of the Russian FederationCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2490-1263
ORCID Icon show all
Pages 1607-1616 | Received 28 Oct 2021, Accepted 17 Jan 2022, Published online: 13 Feb 2022

References

  • Scarfo L, Chatzikonstantinou T, Rigolin GM, et al. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus. Leukemia. 2020;34:2354–2363.
  • Mato AR, Roeker LE, Lamanna N, et al. Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood. 2020;136:1134–1143.
  • Sinisalo M, Aittoniemi J, Oivanen P, et al. Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. Br J Haematol. 2001;114:107–110.
  • Svensson T, Kättström M, Hammarlund Y, et al. Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia a randomized study by the Swedish CLL Group. Vaccine. 2018;36:3701–3707.
  • Mauro FR, Giannarelli D, Galluzzo CM, et al. Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL). Leukemia. 2021;35:737–746.
  • Andrick B, Alwhaibi A, DeRemer DL, et al. Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib. Br J Haematol. 2018;182:712–714.
  • Lindström V, Aittoniemi J, Salmenniemi U, et al. Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia. Hum Vaccin Immunother. 2019;15:2910–2913.
  • van der Velden AM, Mulder AH, Hartkamp A, et al. Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients. Eur J Intern Med. 2001;12:420–424.
  • Sun C, Gao J, Couzens L, et al. Seasonal influenza vaccination in patients with chronic lymphocytic leukemia treated with ibrutinib. JAMA Oncol. 2016;2:1656–1657.
  • Pleyer C, Ali MA, Cohen JI, et al. Effect of bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines. Blood. 2021;137:185–189.
  • International Severe Acute Respiratory and Emerging Infection Consortium and World Health Organisation. Clinical data collection—the COVID-19 case report forms (CRFs). Available from: https://isaric.org/research/covid-19-clinical-research-resources/covid-19-crf/
  • Munblit D, Nekliudov NA, Bugaeva P, et al. Stop COVID cohort: an observational study of 3480 patients admitted to the Sechenov University Hospital Network in Moscow City for suspected coronavirus disease 2019 (COVID-19) infection. Clin Infect Dis. 2021;73:1–11.
  • Sterne JAC, Murthy S, Diaz JV, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324:1330–1341.
  • Investigators R-C, Gordon AC, Mouncey PR, et al. Interleukin-6 receptor antagonists in critically ill patients with covid-19. N Engl J Med. 2021;384:1491–1502.
  • Billett HH, Reyes-Gil M, Szymanski J, et al. Anticoagulation in COVID-19: effect of enoxaparin, heparin, and apixaban on mortality. Thromb Haemost. 2020;120:1691–1699.
  • Feng X, Yin J, Zhang J, et al. Longitudinal profiling of antibody response in patients with COVID-19 in a tertiary care hospital in Beijing, China. Front Immunol. 2021;12:614436.
  • Patil HP, Rane PS, Shrivastava S, et al. Antibody (IgA, IgG, and IgG subtype) responses to SARS-CoV-2 in severe and nonsevere COVID-19 patients. Viral Immunol. 2021;34:201–209.
  • Chew C, Mannepalli S. COVID-19: no guaranteed protection from future infection after the initial diagnosis. Case Rep Infect Dis. 2021;2021:6617719.
  • Sevillano G, Ortega-Paredes D, Loaiza K, et al. Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: a case study. Int J Infect Dis. 2021:108:53–56.
  • Letizia AG, Ge Y, Vangeti S, et al. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir Med. 2021;9(7):712–720.
  • Herold T, Jurinovic V, Arnreich C, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146:128–136 e124.
  • Galvan-Roman JM, Rodriguez-Garcia SC, Roy-Vallejo E, et al. IL-6 serum levels predict severity and response to tocilizumab in COVID-19: an observational study. J Allergy Clin Immunol. 2021;147(1):72–80 e78.
  • Mazzoni A, Salvati L, Maggi L, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020;130:4694–4703.
  • Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123–1130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.